跳至主要内容
临床试验/TCTR20200520002
TCTR20200520002招募中未知

Costs Of type-2 DiabEtes mellitus complications in Thailand

Faculty of Medicine, Chiang Mai University0 个研究点目标入组 330,000 人开始时间: 2020年5月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
330,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1. Patients treated at either OPD or IPD, who were diagnosed as T2DM) ICD-10: E10.xx †E14.xx and excluded T1DM by age and insulin use only) or patients who received any hypoglycemic agents e.g. meglitinides, sulfonylureas, DPP-4 inhibitors, biguanides, thiazolidinediones, alpha-glucosidase inhibitors, SGLT2 inhibitors, insulin.
  • 2. Patients who were either diagnosed as T2DM or received any antihyperglycemic agents at least 2 times within 6-month since diagnosis. This is to confirm that patients are likely to receive continuous treatment.

排除标准

  • Patients with less than 2 records for antihyperglycemic agents

研究者

发起方
Faculty of Medicine, Chiang Mai University

相似试验